Keith D. Dawkins, M.D., Principal Investigator, TAXUS VI Clinical Trial.

Delivering What's Next.™

Boston Scientific is focused. Focused on developing innovative technologies to help clinicians improve the quality of their patients’ lives. Focused on achieving unprecedented milestones. Focused on advancing the quality and delivery of less-invasive medicine. Focused on continued long-term growth.

Today we find ourselves at a pivotal point in our Company’s history, when breakthrough technologies are altering the competitive landscape. We stand at the beginning of a new era in our history, preparing for the opportunity to dramatically grow and expand our business.